A Modified Hybrid Wald's Approximation Method for Efficient Covariate Selection in Population Pharmacokinetic
Yixuan Zou1,2, Fei Tang1, Chee M Ng3,4
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.
Abstract:
One important objective of population pharmacokinetic (PPK) analyses is to identify and quantify relationships between covariates and model parameters such as clearance and volume. To improve upon existing covariate model development methods including stepwise procedures and Wald's approximation method (WAM), this paper introduces an innovative method named the hybrid first-order conditional estimation (FOCE)/Monte-Carlo parametric expectation maximization (MCPEM)-based Wald's approximation method with backward elimination (BE), or H-WAM-BE. Compared with WAM, this new method uses MCPEM to obtain full covariance matrix after running FOCE to obtain full model parameter estimates, followed by BE to select the final covariate model. Two groups of datasets (simulation datasets and rituximab datasets) were used to compare the performance of H-WAM-BE with two other methods, likelihood ratio test (LRT)-based stepwise covariate method (SCM) and H-WAM with full subset approach (H-WAM-F) in NONMEM. Different scenarios with different sample sizes and sampling schemes were used for simulating datasets. The nominal model was used as the reference to evaluate the three methods for their ability to accurately identify parameter-covariate relationships. The methods were compared using the number of true and false positive covariates identified, number of times that they identified the reference model, computation times, and predictive performance. Best-performing H-WAM-BE methods (M2 and M4) showed comparable results with LRT-based SCM. H-WAM-BE required shorter or comparable computation times than LRT-based SCM and H-WAM-F regardless of the model structure, sample size, or sampling design used in this study.
More Related Videos
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Dosage Regimens: Partial Pharmacokinetic Parameters
